WMSA
PRQR icon

Weiss Multi-Strategy Advisers’s ProQR Therapeutics PRQR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-79,300
Closed -$1.72M – 498
2014
Q4 		$1.72M Buy
79,300
+47,140
+147% +$715K 0.06% 229
2014
Q3 		$553K Buy
+32,160
New +$515K 0.01% 430

Other funds holding PRQR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PRQR Position: Q1 2015 in Review

Weiss Multi-Strategy Advisers sold out of ProQR Therapeutics (PRQR) in Q1 2015, closing a stake of 79,300 shares — an estimated $1.72M sold.

Weiss Multi-Strategy Advisers first reported a position in PRQR in Q3 2014 and held it in 2 quarters. The position peaked at $1.72M in Q4 2014. 38 funds tracked by Wall St. Rank hold PRQR as of Q1 2015.

  • Weiss Multi-Strategy Advisers reported no remaining ProQR Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 79,300 ProQR Therapeutics shares in Q1 2015, an estimated $1.72M.
  • Weiss Multi-Strategy Advisers first reported a position in ProQR Therapeutics in Q3 2014 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's ProQR Therapeutics position peaked at $1.72M in Q4 2014.
  • 38 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2015, filed 15 May 2015.